Industry Update

Mobile Health Market To See Record Break Revenue $230 billion By 2027 | Bayer Healthcare., Boston Scientific Corporation

mHealth Market

According to the research report published by Allied Market Research, the global mHealth market is expected to register a CAGR of 22.3% from 2020 to 2027. The research includes changing market dynamics, top impacting factors, key investment pockets, value chain, and competitive scenario. Through tabular and graphical representation, the report offers key insights on different aspects of the market such as current market size and estimations, region-wise analysis, and opportunities. Porter’s Five Forces analysis has been mentioned in the report to outline competitive intensity. The report is a helpful source of information to unlock potential from emerging countries and expand businesses to gain international presence.

Click Here To Access Free Sample Report @

The Covid-19 outbreak has severely affected every sector across the world. The patient numbers have been increasing every day and the majority of the countries are in complete lockdown. This has affected the supply chain and overall business operations. International trading has taken a significant downfall and has created uncertainty in the stock market. These factors have affected the Mobile Health market.

The mHealth report offers an in-depth analysis of the Covid-19 impact on various market segments and countries. Moreover, the report offers major market trends and forecasts, considering the Covid-19 situation.

Mobile health provides health service and information through mobile communication devices to address the health priorities and concerns. The advanced mobile and wireless technologies have transformed the face of healthcare services across the globe and are rendering the growth of mHealth market. Moreover, the continued growth in coverage of mobile cellular networks, rapid advances in mobile technologies & applications, increasing lifestyle diseases and growing awareness among patient population in emerging economies, are some of the key factors fostering the growth of mHealth market. On contrary, the lower accuracy of the devices, technology’s infancy in middle and lower income economies, weak reimbursement coverage, uncertainty in government regulations in certain regions, and low adoption among ageing population is hampering the market growth to a certain extent.

The major factor that contributes toward the growth of the mHealth market include rise in prevalence of lifestyle diseases. Furthermore, factors such as technological innovations, integration of wireless technologies with portable healthcare devices, affordability of smartphones, rise in adoption of mHealth among medical professionals, and favorable government initiatives also boost of mHealth market growth. However, weak reimbur sement coverage associated with mHealth and lack on technological awareness among the aging population hinder the growth of the market. Conversely, lucrative growth potential offered by untapped market of developing economies offers a lucrative opportunity for the mobile health market.

Inquire Before Buying @

The global mHealth market is segmented on the basis of device, service, stakeholder, application, and region to provide a detailed assessment of the market. By device, the market is divided into blood glucose meter, BP monitors, pulse oximetry, neurological monitors, cardiac monitors, apnea & sleep monitors, wearable fitness sensor device & heart rate meters, and others. By service, it is classified into prevention, diagnostic services, monitoring services, treatment, and wellness & healthcare system strengthening solutions. By stakeholder, it is divided into mobile operators, device vendors, healthcare providers, and Application & Content Players. By application, it is categorized into cardiovascular diseases, diabetes, respiratory diseases, neurology diseases, and others. By region, the mHealth market size is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Russia, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and Middle East (Saudi Arabia, Kuwait, UAE, Qatar, Bahrain, Oman, and rest of Middle East), and Latin America & Africa.

On the basis of device, BP monitors held the dominant share in 2019, owing to the factors such as surge in incidence of hypertension, which leads to high blood pressure, and rise in adoption of sedentary lifestyle. However, blood glucose meters is estimated to be the fastest growing segment in the global mHealth devices market due to rise in prevalence of diabetes and surge in adoption of continuous blood glucose monitoring (CGM) devices.

By service, the monitoring services occupied the largest share of mHealth services market in 2019 and is also expected to exhibit fastest growth rate during the forecast period. The growth of the segment is due to factors such as rise in prevalence of diseases, which include blood pressure, diabetes, and cardiovascular diseases which require monitoring of the condition of the patient for prevention and better treatment.

In 2019, North America accounted for the major share of mHealth market size and is expected to continue this trend owing to rise in prevalence of diabetes, blood pressure, cardiovascular diseases, and others. Moreover, other factors such as easy availability of mHealth devices and services, and surge in adoption of these devices boost the market growth in this region. Asia-Pacific is expected to exhibit fastest growth rate owing to surge in awareness related to use of mHealth devices. The other factors that boost the growth of the market include huge patient base of diabetes and rise in healthcare expenditure in the region. The developing economies offer lucrative opportunities for mHealth providers to expand their business.

Access Full Report @

The Major Key Players Are:

Bayer Healthcare., Boston Scientific Corporation, Dexcom, Inc., Johnson & Johnson, Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, Omron Corporation, Samsung Group, and Sanofi.


David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

About Us

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.

Source link

Related posts

Spine Surgery Products Market – key players covered:Stryker, Globus Medical, Zimmer Biomet, K2M, Orthofix International, Alphatec, RTI Surgical, B. Braun, Xtant Medical


Hyperuricemia Drugs Market 2020 Industry Shares Report Analysis | Global Players – Takeda Pharmaceuticals , Mylan N.V., Dr. Reddy’s Laboratories, Sanofi., Sandoz AG.


Global Cardiac safety services Market by Application, Analysis, Type, forecast 2020 to 2028, key players are Biotrial, Banook Group, Bioclinica, Certara L.P., Celerion